[HTML][HTML] Global partnerships for HPV vaccine must look beyond national income

Z Shinkafi-Bagudu - JCO Global Oncology, 2020 - ncbi.nlm.nih.gov
A global strategy aimed at eliminating cervical cancer by 2030 was released by WHO and
was recently adopted by many countries and partners. However, few diseases reflect global …

[HTML][HTML] Spotlight on human papillomavirus vaccination coverage: is nigeria making any progress?

EA Okolie, BI Nwadike - JCO Global Oncology, 2023 - ncbi.nlm.nih.gov
The tragedy of losing one woman every 2 minutes to cervical cancer is regrettable in the
face of advancements in cervical cancer prevention and treatment. 1 Despite being a largely …

[HTML][HTML] Stemming the wave of cervical cancer: human papillomavirus vaccine introduction in India

R Mehrotra, R Hariprasad, P Rajaraman… - Journal of Global …, 2018 - ncbi.nlm.nih.gov
With the highest burden of cervical cancer mortality in the world, India faces enormous loss
of life, productivity, and suffering from this disease. The age-standardized incidence ratio for …

[HTML][HTML] Global disparities in HPV vaccination

O Ginsburg - The Lancet Global Health, 2016 - thelancet.com
Cervical cancer is the fourth most common cancer in women globally, but remains the
second most common cancer (after breast cancer) in many low-income and middle-income …

[HTML][HTML] Single dose HPV vaccine in achieving global cervical cancer elimination

V Fokom-Defo, I Dille, J Fokom-Domgue - The Lancet Global Health, 2024 - thelancet.com
Globally, cervical cancer remains a public health issue of increasing concern that could be
addressed through the implementation of effective preventive measures such as human …

HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage

G Giannone, AR Giuliano, M Bandini… - Cancer treatment …, 2022 - Elsevier
HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

[PDF][PDF] HPV vaccination strategies targeting hard-to-reach populations: out-of-school girls in LMICs

K Bonner, C Banura, NE Basta - Vaccine, 2018 - chdc.mak.ac.ug
Human papillomavirus (HPV) is the primary cause of cervical cancer (CC) and is also
associated with cancers of the oropharynx, rectum, anus, penis, vulva and vagina as well as …

[HTML][HTML] Cervical Cancer prevalence in sub-Saharan Africa and HPV vaccination policy: a public health grand challenge?

E Asempah - Journal of Cancer Immunology, 2021 - scientificarchives.com
Cervical cancer cases in low-income countries (LICs) are on the rise, whereas the reverse is
true for high-income countries (HICs). With sub-Saharan Africa carrying the highest burden …

Benefits, cost requirements and cost-effectiveness of the HPV16, 18 vaccine for cervical cancer prevention in developing countries: policy implications

SJ Goldie, M O'Shea, M Diaz, SY Kim - Reproductive health matters, 2008 - Elsevier
Approximately 70% of cases of cervical cancer worldwide are caused by genotypes 16 and
18 of human papillomavirus (HPV), which is sexually transmitted. With the availability of an …

[PDF][PDF] Controversial new vaccine to prevent cervical cancer

J Parry - Bulletin of the World Health Organization, 2006 - SciELO Public Health
A woman in the United States has a 70% chance of surviving cervical cancer thanks to
relatively easy access to Pap smears or tests to detect early signs of cancer, as well as …